Investor scrutiny mounts over Oscar Health's financial health following Mark T. Bertolini's appointment as CEO, with questions raised about cash flow and sustainability.
2 reports, 2 independent
Updated Aug 13
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Investor scrutiny mounts over Oscar Health's financial health following Mark T. Bertolini's appointment as CEO, with questions raised about cash flow and sustainability.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Oscar Health
U.S. health insurance company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- StockStoryThe Top 5 Analyst Questions From Oscar Health’s Q2 Earnings Call Oscar Health’s second quarter was marked by robust top-line growth, but the company missed Wall Street’s revenue and non-GAAP EPS esti
- Business WireOscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance NEW YORK, August 06, 2025--(BUSINESS WIRE)--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: O